ROS-responsive liposomes with NIR light-triggered doxorubicin release for combinatorial therapy of breast cancer.
Hanxi YiWangxing LuFan LiuGuoqing ZhangFeifan XieWenjie LiuLei WangWenhu ZhouZe-Neng ChengPublished in: Journal of nanobiotechnology (2021)
Lipo/pB-DOX/ICG is a novel tool for on-demand drug release at tumor site and also a promising candidate for controllable and accurate combinatorial tumor therapy.